Welcome to another Still in the Storm Substack post.
I have a new addition to the website that I couldn’t wait to share.
As a scientist and researcher who is always learning it is definitely frustrating when someone who is sharing knowledge is inaccessible.
For some there is no way to contact them to ask a question or comment on content they’ve put out.
I would like to take a cue from our Lord’s words, “do unto others as you would have them do unto you,” and so I have created an FAQ page.
Want to submit a question for the FAQ page?
First, check to see if I have already answered your question on the FAQ page.
If I have NOT, then go ahead and click the button below to submit a question.
The question will appear near the top of the FAQ page as soon as I get the time to answer it.
Take Action!
For today’s take action please click on the button below and submit a question for our new FAQ page.
Do you know someone that could benefit from this?
If you find the information in these articles valuable, we would be grateful for your help to get it to those who could most benefit.
Just click the button below to share and restack today’s post! You can share it to social media too. Everything helps.
Get notified when new posts go live!
Lastly, to be notified as soon as a new post is live go ahead and subscribe to Still in the Storm by clicking the button below.
Get Caught Up… Here are the Last Few Posts
If you like this post why not share and restack it?
Thanks so much, Mike. I'll post a question now.
Hello Mike,
I have some questions.
(1) Do you know of any published valid "SARS-CoV-2" negative controls for CPE (cytopathic effect)? (excluding unpublished Stefan Lanka's experiments).
I haven't found anything in the literate thus far (pubmed, google etc). They are either omitted, invalid or undocumented.
There is this paper https://www.nature.com/articles/s41467-021-22166-4 but this for cell death not CPE ("Importantly, we saw no differences in cell number between mock and SARS-CoV-2 infected cells at the time of metabolite extraction 24 h post SARS-CoV-2 infection, suggesting no measurable difference in cell death") and the full materials and methods of the mock are not documented.
I am aware of these studies but they are not for SARS-CoV-2 and are quite dated.
ENDERS JF, PEEBLES TC. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med. 1954;86(2):277-286. https://pubmed.ncbi.nlm.nih.gov/13177653/
RUSTIGIAN R, JOHNSTON P, REIHART H. Infection of monkey kidney tissue cultures with virus-like agents. Proc Soc Exp Biol Med. 1955;88(1):8-16. https://https://pubmed.ncbi.nlm.nih.gov/14357329/
COHEN SM, GORDON I, RAPP F, MACAULAY JC, BUCKLEY SM. Fluorescent antibody and complement-fixation tests of agents isolated in tissue culture from measles patients. Proc Soc Exp Biol Med. 1955;90(1):118-122. https://pubmed.ncbi.nlm.nih.gov/13273372/
BECH V, VON MAGNUS P. Studies on measles virus in monkey kidney tissue cultures. 1. Isolation of virus from 5 patients with measles. Acta Pathol Microbiol Scand. 1958;42(1):75-85. https://pubmed.ncbi.nlm.nih.gov/13508250/
Magnus, P.v., Andersen, E.K., Petersen, K.B. and Birch-Andersen, A. (1959), A POX-LIKE DISEASE IN CYNOMOLGUS MONKEYS. Acta Pathologica Microbiologica Scandinavica, 46: 156-176. https://doi.org/10.1111/j.1699-0463.1959.tb00328.x
(2) In this paper https://doi.org/10.1016/j.cell.2020.05.042 on page 431 under Figure 1(C) it states
"CPE and GFP signals were observed in Vero-E6 cells electroporated with sub-genomic RNA (sgRNA)-N alone (mock) or sgRNA-N mixed with full-length RNA transcripts (recombinant viruses) at two days after transfection. Scale bar, 100 mm."
(a) Do you know what "sub-genomic RNA (sgRNA)-N alone" means?
(b) Would you consider this as a valid negative control (i.e., no "SARS-CoV-2") for CPE?
Thank You,
Dmitry